Cargando...
Perspectives on the clinical development of immunotherapy in prostate cancer
Despite impressive survival benefits with immunotherapy in patients with various solid tumors, the full potential of these agents in prostate cancer has yet to be realized. Sipuleucel-T demonstrated a survival benefit in this population, indicating that prostate cancer is an immunoresponsive disease...
Guardado en:
| Publicado en: | Asian J Androl |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5952479/ https://ncbi.nlm.nih.gov/pubmed/29582792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/aja.aja_9_18 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|